Chemically modified oligonucleotides exhibit decreased immune stimulation in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 2, 2000, Pages 468-479

  Henry, Scott ^a   Stecker, Kim ^a   Brooks, Doug ^a   Monteith, David ^a   Conklin, Boyd ^a   Bennett, C Frank ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; OLIGONUCLEOTIDE;

ANIMAL EXPERIMENT; ARTICLE; CELL INFILTRATION; CHEMICAL MODIFICATION; GENE THERAPY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLENOMEGALY;

ALANINE TRANSAMINASE; ANIMALS; CELL ADHESION; CELL MOVEMENT; CYTOKINES; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; ORGAN SIZE; PLATELET COUNT; THIONUCLEOTIDES;

EID: 0033965192     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Altmann KH, Fabbro D, Dean NM, Geiger T, Monia BP, Mueller M and Nicklin P (1996) Second-generation antisense oligonucleotides: Structure-activity relationships and the design of improved signal transduction inhibitors. Biochem Soc Trans 24:630-637.
2. Baker BF, Lot SS, Condon TP, Cheng-Flournoy S, Lesnik EA, Sasmor HM and Bennett CF (1997) 2′-O-(2-methoxy) ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J Biol Chem 272:11994-12000.
3. Beaucage SL and Iyer RP (1992) Advances in the synthesis of oligonucleotides by the phosphoramidite approach. Tetrahedron 48:2223-2311.
4. Bennett CF (1998) Antisense oligonucleotides: Is the glass half full or half empty? Biochem Pharmacol 55:9-19.
5. Bennett CF and Condon TP (1998) Use of antisense oligonucleotides to modify inflammatory processes, in Antisense Research Applications (Crooke ST ed) pp 371-393, Springer Verlag, Berlin.
6. Bennett CF, Dean N, Ecker DJ and Monia BP (1996) Pharmacology of antisense therapeutic agents - cancer and inflammation, in Methods in Molecular Medicine: Antisense Therapeutics (Agrawal S ed) pp 13-46, Humana Press Inc., Totowa, NJ.
7. Bennett CF, Kornbrust D, Henry S, Stecker K, Howard R, Cooper S, Dutson S, Hall W and Jacoby HI (1997) An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J Pharmacol Exp Ther 280:988-1000.
8. Boggs RT, McGraw K, Condon T, Flournoy S, Villiet P, Bennett CF and Monia B (1997) Characterization of immune stimulation by modified oligonucleotides. Antisense Nucleic Acid Drug Dev 7:461-471.
9. Branda RF, Moore AL, Lafayette AR, Mathews L, Hong R, Zon G, Brown T and Mccormack JJ (1996) Amplification of antibody production by phosphorothioate oligodeoxynucleotides. J Lab Clin Med 128:329-338.
10. Branda RF, Moore AL, Mathews L, McCormack JJ and Zon G (1993) Immune stimulation by an antisense oligomer complimentary to the rev gene of HIV-1. Biochem Pharmacol 45:2037-2043.
11. Crooke RM, Crooke ST, Graham MJ and Cooke ME (1996) Effect of antisense oligonucleotides on cytokine release from human keratinocytes in an in vitro model of skin. Toxicol Appl Pharmacol 140:85-93.
12. Cummins LL, Owena SR, Risen LM, Lesnik EA, Freier SM, McGee D, Guinosso CJ and Cook PD (1995) Characterization of fully 2′-modified oligoribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity. Nucleic Acids Res 23:2019-2024.
13. Dean NM and McKay R (1994) Inhibition of protein kinase C-α expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc Nat Acad Sci USA 91:11762-11766.
14. Dean NM, McKay R, Condon TP and Bennett C (1994) Inhibition of protein kinase C-α expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J Biol Chem 269:16416-16424.
15. Geary RS, Leeds JM, Fitchett J, Burckin T, Troung L, Spainhour C, Creek M and Levin AA (1997) Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression. Drug Metab Dispos 25:1272-1281.
16. Henry SP, Grillone LR, Orr JL, Brunner RH and Kornbrust DJ (1997a) Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate oligonucleotides, following subacute intradermal administration in Sprague-Dawley rats. Toxicology 116:77-88.
17. Henry SP, Monteith D and Levin AA (1997b) Antisense oligonucleotide inhibitors for the treatment of cancer: 2. Toxicologic properties of phosphorothioate oligodeoxynucleotides. Anticancer Drug Des 12:395-408.
18. Henry SP, Taylor J, Midgley L, Levin AA and Kornbrust DJ (1997c) Evaluation of the toxicity profile of ISIS 2302, a phosphorothioate oligonucleotide in a 4-week study in CD-1 mice. Antisense Nucleic Acid Drug Dev 7:473-481.
19. Klinman DM, AE-Kyung Y, Beaucage SL, Conover J and Krieg AM (1996) CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc Natl Acad of Sci USA 93:2879-2883.
20. Krieg AM, Matson S and Fisher E (1996) Oligonucleotide modification determine the magnitude of B-cell stimulation by CpG motifs. Antisense Nucleic Acid Drug Dev 6:133-139.
21. Krieg AM, Yi A-K, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA and Klinman DM (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (Lond) 374:546-549.
22. Levin AA, Monteith DK, Leeds JM, Nicklin PL, Geary RS, Butler M, Templin MV and Henry SP (1998) Toxicity of oligodeoxynucleotide therapeutic agents, in Antisense Research and Applications (Crooke ST ed) pp 169-215, Springer Verlag, Berlin.
23. Liang H, Nishioka Y, Reich CF, Pisetsky DS and Lipsky PE (1996) Activation of human B cells by phosphorothioate oligodeoxynucleotides. J Clin Invest 98:1119-1129.
24. McKay RA, Cummins LL, Graham M, Lesnik EA, Owens SR, Winniman M and Dean NM (1996) Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-alpha by the incorporation of 2′-O-propyl modifications. Nucleic Acids Res 24:411-417.
25. Monia BP and Dean NM (1998) Pharmacological activity of antisense oligonucleotides in animal models of disease, in Antisense Research and Applications (Crooke ST ed) pp 427-443, Springer Verlag, Berlin.
26. Monia BP, Johnston JF, Sasmor H and Cummins LL (1996) Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras. J Biol Chem 24:14533-14540.
27. Monia BP, Lesnik EA, Gonzalez C, Lima WF, McGee D, Guinosso CJ, Kawasaki AM, Cook PD and Freier SM (1993) Evaluation of 2′ modified oligonucleotides containing deoxy gaps as antisense inhibitors of gene expression. J Biol Chem 268:14514-14522.
28. Monteith DK, Henry SP, Howard RB, Flournoy S, Levin AA, Bennett CF and Crooke ST (1997) Immune stimulation-a class effect of phosphorothioate oligodeoxynucleotides in rodents. Anticancer Drug Des 12:421-432.
29. Pisetsky DS and Reich CF (1994) Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virus. Life Sci 54:101-107.
30. Sarmiento UM, Perez JR, Becker JM and Ramaswamy N (1994) In vivo toxicological effects of rel A antisense phosphorothioates in CD-1 mice. Antisense Res Dev 4:99-107.
31. Srinivasan SK, Tewary HK and Iversen PL (1995) Characterization of binding sites, extent of binding, and drug interactions of oligonucleotides with albumin. Antisense Res Dev 5:131-139.
32. Yamamoto T, Yamamoto S, Kataoka T and Tokunaga T (1994) Ability of oligonucleotides with certain palindromes to induce interferon production and augment natural killer cell activity is associated with their base length. Antisense Res Dev 4:119-122.
33. Zhao Q, Temsamani J, Iadarola PL, Jiang Z and Agrawal S (1995) Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Biochem Pharmacol 51:173-182.
34. Zhao Q, Temsamani J, Zhou R-Z and Agrawal S (1997) Pattern and kinetics of cytokine production following administration of phosphorothioate oligonucleotides in mice. Antisense Nucleic Acid Drug Dev 7:495-502.